Implications of a Reduction in the Hemoglobin Target in Erythropoiesis-Stimulating Agent-Treated Hemodialysis Patients

Publisher： Karger

E-ISSN： 1664-5529|1|1|212-216

ISSN： 1664-5529

Source： Nephron Extra, Vol.1, Iss.1, 2011-11, pp. : 212-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Minor Elevation in C-Reactive Protein Levels Predicts Incidence of Erythropoiesis-Stimulating Agent Hyporesponsiveness among Hemodialysis Patients

By  

Nephron, Vol. 131, Iss. 2, 2015-0 ,pp. : 123-130

Karger

Access to resources Recommend Favorite

Levocarnitine Injections Decrease the Need for Erythropoiesis-Stimulating Agents in Hemodialysis Patients with Renal Anemia

By  

Cardiorenal Medicine, Vol. 7, Iss. 3, 2017-04 ,pp. : 188-197

Karger

Access to resources Recommend Favorite

The Impact of Lowering Haemoglobin Targets on Patterns of Erythropoiesis-Stimulating Agent Use in Patients on Haemodialysis

By  

Blood Purification, Vol. 41, Iss. 4, 2016-01 ,pp. : 287-292

Karger

Access to resources Recommend Favorite

Possible Inhibitory Effect of Erythropoiesis-Stimulating Agents at the Predialysis Stage on Early-Phase Coronary Events after Hemodialysis Initiation

By  

Cardiorenal Medicine, Vol. 7, Iss. 1, 2016-08 ,pp. : 21-30

Karger

Access to resources Recommend Favorite

Pre-Emptive Replacement of Water Treatment Components Improves Responsiveness to Erythropoiesis-Stimulating Agents in Maintenance Haemodialysis Patients: A Quality Improvement Report

By  

Blood Purification, Vol. 36, Iss. 3-4, 2013-12 ,pp. : 265-273

Karger

Access to resources Recommend Favorite